SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001104659-21-111097
Filing Date
2021-08-30
Accepted
2021-08-30 17:02:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7749
  Complete submission text file 0001104659-21-111097.txt   8834
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations